secret information

Secret information about Alzheimer's drug used for greedy insider trading

Tuesday, December 04, 2012 by: Sherry Baker, Health Sciences Editor
Tags: Alzheimer''s drugs, insider trading, secret information

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
CDC issues flu vaccine apology: this year's vaccine doesn't work!
The five biggest lies about Ebola being pushed by government and mass media
Ultraviolet light robot kills Ebola in two minutes; why doesn't every hospital have one of these?
Tetanus vaccines found spiked with sterilization chemical to carry out race-based genocide against Africans
The best way to help your body protect itself against Ebola (or any virus or bacteria)
Healthy 12-year-old girl dies shortly after receiving HPV vaccine
Cannabis dissolves cancerous tumor in young infant, deemed a 'miracle baby' by physician
Ben & Jerry's switches to non-GMO, Fair Trade ice cream ingredients
Russia throws down the gauntlet: energy supply to Europe cut off; petrodollar abandoned as currency war escalates
W.H.O. contradicts CDC, admits Ebola can spread via coughing, sneezing and by touching contaminated surfaces
Monsanto's seed imperialism halted in Canada thanks to massive protests
Top ten things you need to do NOW to protect yourself from an uncontrolled Ebola outbreak
FDA targets Dr. Bronner's Magic Soaps for sharing health benefits of coconut oil
Why flu shots are the greatest medical fraud in history
Governments seize colloidal silver being used to treat Ebola patients, says advocate
Flu vaccine kills 13 in Italy; death toll rises
The 21 curious questions we're never allowed to ask about vaccines
CDC admits it has been lying all along about Ebola transmission; "indirect" spread now acknowledged

(NaturalNews) Here's another blow to the idea that doctors and scientists are only using their research findings to help patients. It turns out there's a way to make money off drug research that doesn't even involve marketing the drugs. Although it's illegal, it's obviously a tempting way for some greedy folks unencumbered with ethics to make big bucks behind the scenes --- just take drug research info that hasn't been made public and secretly share this insider information with stock manipulators.

Consider this scheme that has just come to light. Sid Gilman was chairman of a safety-monitoring committee that watched over a clinical trial by Big Pharma's Wyeth LLC and Elan Corp. The study was designed to see if a drug called bapineuzumab, or bapi, was safe and helpful for patients with Alzheimer's disease. Meanwhile, according to the U.S. Justice Department and the Securities and Exchange Commission, Gilman was also pulling in big bucks on the side providing advice to then SAC portfolio manager Mathew Martoma.

Apparently, Gilman was leaking Martoma secret information about bapi for a year and a half in a huge money-making scheme. Specifically, bapi wasn't working. Like something out of a spy movie, Gilman and Martoma are alleged to have shared info using encrypted files and passwords.

Using the leaked drug trial results from Gilman, the indictments say, Martoma conducted insider trading. The SEC has sued, claiming Gilman's secretly leaked data allowed the Stamford, Connecticut-based SAC and its CR Intrinsic Investors unit to sell over than $960 million in Elan and Wyeth securities before a July 29, 2008, announcement that the bapi drug was a failure.

A just unsealed FBI complaint against Martoma doesn't mention Gilman or say he is charged with a crime. He was specifically named in a non-prosecution agreement released by prosecutors; however, it orders him to forfeit $186,781 he collected for providing the tips. In other words, he's turning state's evidence.

"He (Gilman) is prepared to testify in connection with a non-prosecution agreement," U.S. Attorney Preet Bharara said earlier this week at a news conference held in New York City. Bharara refused to answer questions about why no charges were filed against Gilman, who is a University of Michigan neurologist and director of the Michigan Alzheimer's Disease Research Center in the university's medical school.

In an interview with Bloomberg News, Erik Gordon, a University of Michigan business professor who follows the Big Pharma industry, said Gilman's conduct raises compelling issues about firms that match investors with experts who have information about subjects which can cause stock prices to rise or fall.

"If the allegations are true, it's reprehensible conduct for someone who has misused a position of trust," Gordon told Bloomberg. "This is crookery of really the lowest possible ethical standards. It doesn't get much lower."


About the author:
Sherry Baker is a widely published writer whose work has appeared in Newsweek, Health, the Atlanta Journal and Constitution, Yoga Journal, Optometry, Atlanta, Arthritis Today, Natural Healing Newsletter, OMNI, UCLA''''s "Healthy Years" newsletter, Mount Sinai School of Medicine''''s "Focus on Health Aging" newsletter, the Cleveland Clinic''''s "Men''''s Health Advisor" newsletter and many others.

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...


Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of, the internet's No. 1 natural health news site. (Source:

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.